Current Report Filing (8-k)
July 26 2016 - 4:08PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 26, 2016
NUVASIVE, INC.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-50744
|
|
33-0768598
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification Number)
|
7475 Lusk Boulevard, San Diego, California 92121
(Address of principal executive offices) (Zip Code)
(858) 909-1800
(Registrants telephone number, including area code)
n/a
(Former name or
former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions (
see
General Instruction A.2. below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02
|
Results of Operations and Financial Condition.
|
On July 26, 2016,
NuVasive, Inc. (the Company) issued a press release announcing its financial results for the quarter ended June 30, 2016. A copy of this press release is furnished as Exhibit 99.1 to this Current Report.
Item 7.01
|
Regulation FD Disclosure.
|
During a conference call scheduled to be held
at 1:30 p.m. Pacific Time on July 26, 2016, the Companys Chairman and Chief Executive Officer, Chief Financial Officer, and President and Chief Operating Officer will discuss the Companys results for the quarter ended June 30,
2016 and the Companys outlook for the year ending December 31, 2016. The slide presentation for the conference call is furnished as Exhibit 99.2 to this Current Report.
The information contained in this Current Report and the Exhibits hereto shall not be deemed filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth
by specific reference in such a filing.
Item 9.01
|
Financial Statements and Exhibits.
|
|
|
|
|
|
99.1
|
|
Press release issued by NuVasive, Inc. on July 26, 2016
|
|
|
99.2
|
|
Slide presentation
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
|
|
|
NUVASIVE, INC.
|
|
|
By:
|
|
/s/ Quentin Blackford
|
|
|
Quentin Blackford
|
|
|
Executive Vice President and Chief Financial Officer
|
Date: July 26, 2016
EXHIBIT INDEX
|
|
|
Exhibit
Number
|
|
Description
|
|
|
99.1
|
|
Press release issued by NuVasive, Inc. on July 26, 2016
|
|
|
99.2
|
|
Slide presentation
|
Nuvasive (NASDAQ:NUVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nuvasive (NASDAQ:NUVA)
Historical Stock Chart
From Apr 2023 to Apr 2024